As GLP-1 drugs become more complex, their effects on the heart are getting harder to predict
A brief report reviews emerging GLP-1 receptor co-agonists that also target GIPR, GCGR, and other receptors, examining their metabolic benefits alongside known and predicted cardiac effects. The authors highlight substantial…